1,680
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Stigma, problem drug use, and welfare state encounters: changing contours of stigmatization in the era of social investment

&
Pages 277-284 | Received 09 Nov 2017, Accepted 30 Jul 2018, Published online: 10 Dec 2018

References

  • Abrahamson P. 2015. Denmark from an international perspective. In Bengtsson TT, Henriksen M, Larsen JE, editors. The Danish welfare state. New York: Palgrave Macmillan; p. 25–39.
  • Anstice S, Carol JS, Brands B. 2009. Supervised methadone consumption: Client issues and stigma. Subst Use Misuse. 44:794–808.
  • Bjerge B, Houborg E, Edman J, Perälä R. 2016. Concepts and policies directed at drug use in Denmark, Finland and Sweden. In: Hellman M, Berridge V, Duke K, Mold A, editors. Concepts of addictive substances and behaviours across time and place. Oxford, United Kingdom: Oxford University Press; p. 33–56.
  • Bourgois P. 2003. In search of respect: Selling crack in El Barrio. Cambridge: Cambridge University Press.
  • Bourgois P. 2011. Homelessness, addiction, and politically structured suffering in the USA war on drugs. In Hunt G, Milhet M, Bergeron H, editors. Drugs and culture: Knowledge, consumption and policy Farnham: Ashgate; p. 241–259.
  • Cama E, Brener L, Wilson H, von Hippel C. 2016. Internalized stigma among people who inject drugs. Subst Use Misuse. 51:1664–1668.
  • Cantillon B. 2011. The paradox of the social investment state: Growth, employment and poverty in the Lisbon era. J Eur Soc Policy. 21:432–449.
  • Conner K, Rosen D. 2008. ‘You’re nothing but a junkie’: Multiple experiences of stigma in an aging methadone maintenance population. J Soc Work Pract Addict. 8:244–264.
  • Earnshaw V, Smith L, Copenhaver M. 2013. Drug addiction stigma in the context of methadone maintenance therapy: an investigation into understudied sources of stigma. Int J Ment Health Addiction. 11:110–122.
  • Esping-Andersen G. 2002. Why we need a new welfare state. Oxford: Oxford University Press.
  • Fraser S, Moore D. 2011. The drug effect: Health, crime and society (pp. 19–34). Cambridge: Cambridge University Press.
  • Fraser N. 1994. After the family wage: Gender equity and the welfare state. Polit Theory. 44(4):591–618.
  • Fraser S, Moore D, Keane H. 2014. Habits: Remaking addiction. UK: Palgrave Macmillan.
  • Fraser S, Pienaar K, Dilkes-Frayne E, Moore D, Kokanovic R, Treloar C, Dunlop A. 2017. Addiction stigma and the biopolitics of liberal modernity: A qualitative analysis. Int J Drug Policy. 44:192–201.
  • Fraser S, Valentine K. 2008. Substance and substitution: Methadone subjects in liberal societies. Basingtoke: Palgrave Macmillan.
  • Frederiksen M. 2018. Varieties of Scandinavian universalism: A comparative study of welfare justifications. Acta Sociol. 61:3–16.
  • Goffman E. 1963. Stigma—notes on the management of spoiled identity. London: Penguin Books.
  • Gray R. 2010. Shame, labeling and stigma: Challenges to counseling clients in alcohol and other drug settings. Contemp Drug Probl: Interdis Quart. 37:685–703.
  • Hakkarainen P, Hübner L, Laursen L, Hakkarainen L, Ødegård E. 1996. Drug use and public attitudes in the Nordic countries. Discussing Drugs and Contr Policy. 31:126–165.
  • Hemerijck A. 2015. The quiet paradigm revolution of social investment. Soc Polit: Int Stud Gend, State Soc. 22:242–256.
  • Houborg E, Frank VA. 2014. Drug consumption rooms and the role of politics and governance in policy processes. Int J Drug Policy. 25:972–977.
  • Kumar A, Sonpal D, Hiranandani V. 2012. Trapped between ableism and neoliberalism: Critical reflections on disability and employment in India. DSQ. 32:1–18.
  • Kvist J. 2015. Social investment as risk management. In Bengtsson TT, Frederiksen M, Larsen JE, editors. The Danish welfare state. New York: Palgrave Macmillan; 41–55.
  • Lamont M. 2018. Addressing recognition gaps: Destigmatization and the reduction of inequality. Am Sociol Rev. 83:419–444.
  • Lister S, Seddon T, Wincup E, Barrett S, Traynor P. 2008. Street policing of problem drug users. York: Joseph Rowntree Foundation.
  • Lloyd C. 2013. The stigmatization of problem drug users: A narrative literature review. Drug: Educ, Prev Policy. 20:85–95.
  • Luoma JB, Twohig MP, Waltz T, Hayes SC, Roget N, Padilla M, Fisher G. 2007. An investigation of stigma in individuals receiving treatment for substance abuse. Addict Behav. 32:1331–1346.
  • McNeil R, Small W, Wood E, Kerr T. 2014. Hospitals as a ‘risk environment’: An ethno-epidemiological study of voluntary and involuntary discharge from hospital against medical advice among people who inject drugs. Soc Sci Med. 105:59–66.
  • Merrill JO, Rhodes LA, Deyo RA, Marlatt GA, Bradley KA. 2002. Mutual mistrust in the medical care of drug users: The keys to ‘narc’ cabinet. J Gen Intern Med. 17:327–333.
  • Minior T, Galea S, Stuber J, Ahern J, Ompad D. 2003. Racial differences in discrimination experiences and responses among minority substance users. Ethnicity Dis. 13:521–527.
  • Neale J, Nettleton S, Pickering L. 2011. Recovery from problem drug use: What can we learn from the sociologist Erving Goffman? Drug: Educ, Prev Policy. 18:3–9.
  • Nolan B. 2013. What use is ‘social investment”? J Eur Soc Policy. 23:459–468.
  • Notley C, Maskrey V, Holland R. 2012. The needs of problematic drug misusers not in structured treatment—a qualitative study of perceived treatment barriers and recommendations for services. Drug: Educ, Prev Policy. 19:40–48.
  • Paterson B, Hirsch G, Andres K. 2013. Structural factors that promote stigmatization of drug users with hepatitis C in hospital emergency departments. Int J Drug Policy. 24:471–478.
  • Patrick R. 2012. Work as the primary ‘duty’ of the responsible citizen: A critique of this work-centric approach. PPP. 6:5–15.
  • Radcliff P, Stevens A. 2008. Are drug treatment services only for ‘thieving junkie scumbags’? Drug users and the management of stigmatized identities. Soc Sci Med. 67:1065–1073.
  • Reidpath DD, Chan KY, Gifford SM, Allotey P. 2005. He hath the French pox: Stigma, social value and social exclusion. Sociol Health Ill. 27:468–489.
  • Rhodes T, Watts L, Davies S, Martin A, Smith J, Clark D, Craine N, Lyons M. 2007. Risk, shame and public injector: A qualitative study of drug injecting in South Wales. Soc Sci Med. 65:572–585.
  • Rødner S. 2005. I am not a drug abuser, I am a drug user: A discourse analysis of 44 drug users’ construction of identity. Addict Res Theory. 13:333–346.
  • Saraceno C. 2015. A critical look to the social investment approach from a gender perspective. Soc Polit: Int Stud Gender, State & Society. 22:257–269.
  • Simmonds L, Coomber R. 2009. Injecting drug users: A stigmatized and stigmatizing population. Int J Drug Policy. 20:121–130.
  • Smith C. 2010. Socio-spatial stigmatization and the contested space of addiction treatment: Remapping strategies of opposition to the disorder of drugs. Soc Sci Med. 70:859–866.
  • Treloar C, Holt M. 2009. Deficit models and divergent philosophies: service providers’ perspectives on barriers and incentives to drug treatment. Drugs: Educ Prev Polic. 13:367–382.
  • Tyler I, Slater T. 2018. Rethinking the sociology of stigma. Sociol Rev Monographs. 66:721–743.
  • Valentine K, Fraser S. 2008. Trauma, damage and pleasure: Rethinking problematic drug use. Int J Drug Policy. 19:410–416.
  • Weinberg D. 2005. Of others inside: Insanity, addiction and belonging in America. Philadelphia: Temple University Press.
  • Weiss L, McCoy K, Kluger M, Finkelstein R. 2004. Access to and use of health care: Perceptions and experiences among people who use heroin and cocaine. Addict Res Theory. 12:155–165.
  • Whittle HJ, Palar K, Ranadive NA, Turan JM, Kushel M, Weiser SD. 2017. The land of the sick and the land of the healthy: Disability, bureaucracy, and stigma among people living with poverty and chronic illness in the United States. Soc Sci Med. 190:181–189.
  • Woods J, Herman J. 2015. Stigma from the viewpoint of the patient. J Addict Dis. 34:238–247.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.